Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline DOI
F. Christopher Holsinger, Nofisat Ismaila, Douglas R. Adkins

et al.

Journal of Clinical Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 11, 2025

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following guideline development process as outlined in Methodology Manual . follow Conflict Interest Policy Clinical Practice other guidance (“Guidance”) provided by is not a or definitive guide to treatment options. It intended voluntary use clinicians should be used conjunction independent professional judgment. Guidance may applicable all patients, interventions, diseases stages diseases. based on analysis statement standard care. does endorse third-party drugs, devices, services, therapies assumes no responsibility any harm arising from related this information. See complete disclaimer Appendix 1 2 (online only) more PURPOSE To evidence-based transoral robotic surgery (TORS) multidisciplinary management oropharyngeal squamous cell cancer (OPC). METHODS convened Expert Panel evaluate evidence formulate recommendations. The search included studies published between January 1, 2002, August 31, 2024, comprised systematic reviews, meta-analyses, randomized controlled trials, observational studies. Outcomes interest include overall disease-free survival, functional outcomes, quality life. members available informal consensus develop RESULTS A total 58 publications were identified inform base guideline. RECOMMENDATIONS Evidence-based address evaluation workup patients human papillomavirus (HPV)–positive OPC, role TORS, patient selection, adjuvant therapy, HPV-negative TORS salvage recurrent setting. Additional information at www.asco.org/head-neck-cancer-guidelines

Language: Английский

Transoral Robotic Surgery in the Multidisciplinary Care of Patients With Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline DOI
F. Christopher Holsinger, Nofisat Ismaila, Douglas R. Adkins

et al.

Journal of Clinical Oncology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 11, 2025

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following guideline development process as outlined in Methodology Manual . follow Conflict Interest Policy Clinical Practice other guidance (“Guidance”) provided by is not a or definitive guide to treatment options. It intended voluntary use clinicians should be used conjunction independent professional judgment. Guidance may applicable all patients, interventions, diseases stages diseases. based on analysis statement standard care. does endorse third-party drugs, devices, services, therapies assumes no responsibility any harm arising from related this information. See complete disclaimer Appendix 1 2 (online only) more PURPOSE To evidence-based transoral robotic surgery (TORS) multidisciplinary management oropharyngeal squamous cell cancer (OPC). METHODS convened Expert Panel evaluate evidence formulate recommendations. The search included studies published between January 1, 2002, August 31, 2024, comprised systematic reviews, meta-analyses, randomized controlled trials, observational studies. Outcomes interest include overall disease-free survival, functional outcomes, quality life. members available informal consensus develop RESULTS A total 58 publications were identified inform base guideline. RECOMMENDATIONS Evidence-based address evaluation workup patients human papillomavirus (HPV)–positive OPC, role TORS, patient selection, adjuvant therapy, HPV-negative TORS salvage recurrent setting. Additional information at www.asco.org/head-neck-cancer-guidelines

Language: Английский

Citations

1